ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 185 filers reported holding ACCELERON PHARMA INC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,085,000 | -67.9% | 54,071 | -72.9% | 0.02% | -76.6% |
| Q2 2020 | $18,979,000 | +73.3% | 199,218 | +63.5% | 0.09% | +5.6% |
| Q1 2020 | $10,952,000 | +384.2% | 121,866 | +112.8% | 0.09% | +1012.5% |
| Q3 2019 | $2,262,000 | -69.4% | 57,257 | -68.2% | 0.01% | -68.0% |
| Q2 2019 | $7,390,000 | +32.6% | 179,902 | +50.3% | 0.02% | +38.9% |
| Q1 2019 | $5,574,000 | +142.1% | 119,687 | +152.3% | 0.02% | +157.1% |
| Q2 2018 | $2,302,000 | +42.3% | 47,435 | +24.4% | 0.01% | +40.0% |
| Q4 2017 | $1,618,000 | +418.6% | 38,121 | +495.6% | 0.01% | +400.0% |
| Q4 2015 | $312,000 | +13.5% | 6,400 | -20.9% | 0.00% | 0.0% |
| Q2 2014 | $275,000 | -65.6% | 8,089 | -65.1% | 0.00% | -75.0% |
| Q1 2014 | $799,000 | – | 23,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |